Kenalog and Lovaza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Lovaza (omega-3-acid ethyl esters). Common drug interactions include hyperlipidaemia among females and dry mouth among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Lovaza. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.

On Jul, 05, 2026

52 people who take Kenalog and Lovaza together, and have interactions are studied.

What are the common drug interactions of Kenalog and Lovaza, by gender? *:

female:

Hyperlipidaemia (presence of excess lipids in the blood)
Hypersensitivity
Hypertension (high blood pressure)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hypokalaemia (low potassium)
Hypotension (abnormally low blood pressure)
Injection site mass
Malaise (a feeling of general discomfort or uneasiness)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)

male:

Dry mouth
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Abdominal pain upper
Blindness
Blood testosterone decreased
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Headache (pain in head)
Hepatic enzyme increased
Influenza
Insomnia (sleeplessness)

What are the common drug interactions of Kenalog and Lovaza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cellulitis (infection under the skin)

20-29:

Tooth infection

30-39:

n/a

40-49:

Arthralgia (joint pain)
Arthropathy
Asthma
Biliary dilatation
Cardiac failure chronic
Depression
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperhidrosis (abnormally increased sweating)
Hyperlipidaemia (presence of excess lipids in the blood)
Hypersensitivity

50-59:

Carbon dioxide increased
Fluid retention (an abnormal accumulation of fluid in the blood)
Urinary tract infection
Abdominal discomfort
Ageusia (loss of taste functions of the tongue)
Agitation (state of anxiety or nervous excitement)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anosmia (partial or complete loss of the sense of smell)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cancer in remission (a decrease in or disappearance of signs and symptoms of cancer)

60+:

Dry mouth
Dizziness
Chronic kidney disease
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease recurrence
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gout (uric acid crystals building up in the body)
Headache (pain in head)
Injection site mass
Overdose

What are the existing conditions these people have? *

Stress And Anxiety: 10 people, 19.23%
Constipation: 9 people, 17.31%
Hypersensitivity: 6 people, 11.54%
Insomnia (sleeplessness): 6 people, 11.54%
Nausea (feeling of having an urge to vomit): 5 people, 9.62%
Anaemia (lack of blood): 5 people, 9.62%
Dry Skin: 5 people, 9.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 9.62%
Vitamin D Decreased: 5 people, 9.62%
Abdominal Pain: 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Lovaza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously